Brief: Cue Biopharma Reports Third Quarter 2022 Financial Results
Nov 14 (Reuters) - Cue Biopharma Inc CUE.O :
* CUE BIOPHARMA REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS
* QTRLY NET LOSS PER COMMON SHARE $0.31
* Q3 EARNINGS PER SHARE VIEW $-0.38 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX7spY3M
Further company coverage: CUE.O
((Reuters.Briefs@thomsonreuters.com;))